// App-Quantinova.ai

: A Novel Oral Histone Deacetylase Inhibitor Chidamide Is Highly Effective and Well-Tolerated in Adult Early T-Cell Precursor and Ph-like Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Hongsheng Zhou

Principal Investigators

  • Ya Gao

  • Qiang Wang

  • Rui Cao

  • Zhongxin Zhen

  • Qiuli Li

  • Dainan Lin

  • Linlin Zhou

  • Changxin Yin

  • Han He

  • Xiaoli Liu

  • Bing Z Carter

  • Qifa Liu

Medical Centers

  • Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China

  • Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, HOUSTON, TX

Locations

  • China

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Pegaspargase

  • Chidamide

  • dasatinib

Outcome

  • N/A

Study Design

  • Open Label

  • Cohort

Phase

  • NA

Study Id's

  • NCT03553238

  • NCT03564470

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved